Mesenchymal Stromal Cells: What Is the Mechanism in Acute Graft-Versus-Host Disease?
After more than a decade of preclinical and clinical development, therapeutic infusion of mesenchymal stromal cells is now a leading investigational strategy for the treatment of acute graft-versus-host disease (GVHD). While their clinical use continues to expand, it is still unknown which of their...
Main Authors: | Neil Dunavin, Ajoy Dias, Meizhang Li, Joseph McGuirk |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-07-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/5/3/39 |
Similar Items
-
Comparison of Mesenchymal Stromal Cells From Different Origins for the Treatment of Graft-vs.-Host-Disease in a Humanized Mouse Model
by: Céline Grégoire, et al.
Published: (2019-04-01) -
Tissue immune profiles supporting response to mesenchymal stromal cell therapy in acute graft-versus-host disease—a gut feeling
by: Caroline Gavin, et al.
Published: (2019-11-01) -
Multipotent mesenchymal stromal cells application for acute graft versus host disease treatment
by: L. A. Kuzmina, et al.
Published: (2020-09-01) -
Mesenchymal Stromal Cells for Graft Versus Host Disease: Mechanism-Based Biomarkers
by: Tik Shing Cheung, et al.
Published: (2020-06-01) -
Mesenchymal stromal cells for the prophylaxis and treatment of graft-versus-host disease—a meta-analysis
by: Cynthia Morata-Tarifa, et al.
Published: (2020-02-01)